- Home
- EYPT vs CGBD Comparison
EYPT vs CGBD Comparison
Compare EYPT & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- CGBD
- Stock Information
- Founded
- EYPT 1987
- CGBD 2012
- Country
- EYPT United States
- CGBD United States
- Employees
- EYPT N/A
- CGBD N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- CGBD Finance: Consumer Services
- Sector
- EYPT Industrials
- CGBD Finance
- Exchange
- EYPT Nasdaq
- CGBD Nasdaq
- Market Cap
- EYPT 967.4M
- CGBD 881.4M
- IPO Year
- EYPT 2005
- CGBD 2017
- Fundamental
- Price
- EYPT $11.76
- CGBD $12.73
- Analyst Decision
- EYPT Strong Buy
- CGBD Hold
- Analyst Count
- EYPT 5
- CGBD 5
- Target Price
- EYPT $27.40
- CGBD $14.25
- AVG Volume (30 Days)
- EYPT 1.4M
- CGBD 625.3K
- Earning Date
- EYPT 11-05-2025
- CGBD 11-04-2025
- Dividend Yield
- EYPT N/A
- CGBD 12.37%
- EPS Growth
- EYPT N/A
- CGBD N/A
- EPS
- EYPT N/A
- CGBD 1.14
- Revenue
- EYPT $51,898,000.00
- CGBD $234,464,000.00
- Revenue This Year
- EYPT N/A
- CGBD $15.09
- Revenue Next Year
- EYPT N/A
- CGBD $5.69
- P/E Ratio
- EYPT N/A
- CGBD $11.18
- Revenue Growth
- EYPT 2.99
- CGBD N/A
- 52 Week Low
- EYPT $3.91
- CGBD $11.65
- 52 Week High
- EYPT $14.91
- CGBD $18.64
- Technical
- Relative Strength Index (RSI)
- EYPT 42.93
- CGBD 51.46
- Support Level
- EYPT $11.15
- CGBD $12.68
- Resistance Level
- EYPT $12.47
- CGBD $13.05
- Average True Range (ATR)
- EYPT 0.68
- CGBD 0.26
- MACD
- EYPT -0.08
- CGBD 0.11
- Stochastic Oscillator
- EYPT 23.37
- CGBD 75.00
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.